What is RGEN's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 11.04B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for RGEN?

P/E (TTM) is 265.77 and 52-week range is $100.99 to $198.87 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s RGEN figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for RGEN?

The company profile lists revenue (TTM) near $782M, net income (TTM) near $41M, EPS (TTM) near $0.73 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Repligen Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Waltham, Massachusetts, US, 56.4M shares outstanding, ISIN US7599161095 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Repligen Corp

$RGEN

Health Care · Life Sciences Tools & Services

IR Run Scenarios

$173.88

+6.13%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.

Employees

2,000

Website

www.repligen.com/

IPO

1986-04-29

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)